Noah Goodman
Fortuna: 5 M $ al 30/06/2026
Fortuna: 5 M $ al 30/06/2026
Mr. Noah Goodman is a Chief Business Officer at Kymera Therapeutics, Inc. Mr. Goodman was previously employed as a President & Chief Business Officer by Chroma Medicine, Inc., an Executive Director & Head-Business Development by Cadent Therapeutics, Inc., and a Head-Business Development by Spark Therapeutics, Inc. He received his undergraduate degree from the University of Michigan and an MBA from The Wharton School of the University of Pennsylvania.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/07/2026 | 47.179 ( 0,06 % ) | 5 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Corporate Officer/Principal | 09/04/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | Presidente | 01/04/2025 |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders | Director/Miembro de la Junta | 01/03/2021 |
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.